Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
47.87
+0.02 (0.04%)
At close: Oct 10, 2025, 4:00 PM EDT
47.88
+0.01 (0.02%)
After-hours: Oct 10, 2025, 7:50 PM EDT
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $1.24 billion as of October 10, 2025. Its market cap has increased by 92.66% in one year.
Market Cap
1.24B
Enterprise Value
995.92M
1-Year Change
92.66%
Ranking
Category
Stock Price
$47.87
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $1.24B, an increase of 457.14%. That is a compound annual growth rate of 138.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 1.24B | 137.49% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
| Oct 20, 2023 | 221.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |